Terumo strikes a deal with Olympus for its GlideWire urology device, 2 years after spiking a similar deal with Boston Scientific.
An FDA advisory panel unanimously declares endoscopes unsafe, but splits over what to do about the devices, which have been implicated in scores of so-called 'superbug' infections.
An FDA advisory panel last week declared that duodenoscopes, linked to sometimes lethal antibacterial-resistant outbreaks across the U.S., are unsafe as designed.
The panel urged the FDA to act on this information, but didn't ask for a halt to further use of the devices.
Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific challenges Nevro patent; Boston Scientific settles mesh lawsuit; Feds clear Masimo in Pronto, Pronto-7 probe; Seattle hospital joins 'superbug' suit against Olympus; Siemens settles federal beef for $6m
A Seattle hospital joins a lawsuit filed against Olympus over the endoscope it makes that's been linked to a spate of fatal 'superbug' infections.
UPDATED May 12, 2015, with comment from Olympus.
Johnson & Johnson revives the Kilmer Conference on sterility assurance and sterilization after a series of high-profile - and sometimes deadly - 'superbug' infections.
Johnson & Johnson (NYSE:JNJ) said today that it's planning to revive the sterility assurance and sterilization conference it ran for 27 years before closing up shop in 2003.
Here's a look at some of the top legal news stories for medical device companies this week: Olympus to pay $92m to settle accounting fraud case; Insurer wants out of $28m Biotronik legal loss; Medtronic to pay feds $4m to settle product labeling case
Here's a look at some of the top Wall Street stories for medical device companies this week: Johnson & Johnson taps Google for robot-assisted surgery program; Olympus to pay $92m to settle accounting fraud case; Philips sells stake in lighting biz for $3B; ReWalk Robotics plans Q2 launch in India